Current status:
Cancelled Post Market
Current status date:
2018-11-12
Product name:
METHOXISAL-C 1/4
DIN:
01966367
Electronic product monograph is not available
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS):
See footnote 3
12:20.04
,
28:08.08
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N02AA59 CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS
List of active ingredient(s)
Active ingredient(s) |
Strength |
ACETYLSALICYLIC ACID
|
325 MG
|
CODEINE PHOSPHATE
|
16.2 MG
|
METHOCARBAMOL
|
400 MG
|
A Canadian Specific Opioid targeted Risk Management Plan (CSO-tRMP) for this product was submitted.